Serum N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Critical Pulmonary Stenosis in Neonates
Rank correlation
DOI:
10.3389/fped.2021.788715
Publication Date:
2022-01-05T08:12:25Z
AUTHORS (5)
ABSTRACT
Objectives: To determine the efficacy of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in predicting critical pulmonary stenosis (CPS) neonates. Methods: All neonates with (PS) admitted to neonatal intensive care unit Xinhua Hospital from October 2014 December 2020 were retrospectively reviewed. Infants NT-proBNP measured within 48 h after birth enrolled and divided into CPS non-CPS groups. Serum cardiac Doppler indices compared between two Correlations determined using Spearman's rank correlation coefficient. Receiver operator characteristic curve analysis was used explore predictive value for identifying CPS. Results: Among 96 infants diagnosed PS by echocardiography, 46 (21 25 groups, respectively). significantly higher group than [3,600 (2,040-8,251) vs. 1,280 (953-2,386) pg/ml, P = 0.003]. suggested a positive Ln(NT-proBNP) transvalvular gradient (r 0.311, 0.038), as well artery velocity 0.308, 0.040). operating showed that cutoff level 2,395 pg/ml yielded 66.7 78.9% sensitivity specificity CPS, respectively. The area under 0.784 (95% CI, 0.637-0.931). A found length hospital stay 0.312, < 0.05). Conclusion: positively correlated severity could be biomarker identify
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....